Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mark W. Holladay is active.

Publication


Featured researches published by Mark W. Holladay.


Archive | 2004

Pyridazine derivatives and their use as therapeutic agents

Nagasree Chakka; Mikhail Chafeev; Sultan Chowdhury; Jianmin Fu; Duanjie Hou; Rajender Kamboj; Vishnumurthy Kodumuru; Shifeng Liu; Vandna Raina; Shaoyi Sun; Serguei Sviridov; Michael D. Winther; Zaihui Zhang; Melwyn Abreo; Mark W. Holladay; Wenbao Li; Sengen Sun; Chi Tu; Heinz W. Gschwend


Archive | 2001

Potassium channel openers

Robert J. Altenbach; Hao Bai; Jorge D. Brioni; William A. Carroll; Murali Gopalakrishnan; Robert J. Gregg; Mark W. Holladay; Peggy P. Huang; John F. Kincaid; Michael E. Kort; Philip R. Kym; John K. Lynch; Arturo Perez-Medrano; Henry Q. Zhang


Archive | 2004

Piperazine derivatives and their use as therapeutic agents

Serguei Sviridov; Vishnumurthy Kodumuru; Shifeng Liu; Melwyn Abreo; Michael D. Winther; Heinz W. Gschwend; Rajender Kamboj; Shaoyi Sun; Mark W. Holladay; Wenbao Li; Chi Tu


Archive | 1998

Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission

Mark W. Holladay; Melwyn Abreo; David E. Gunn; Nan-Horng Lin; David S. Garvey; Keith B. Ryther; Suzanne A. Lebold; Richard L. Elliott; Yun He; James T. Wasiak; Hao Bai; Michael J. Dart; Paul Ehrlich; Yihong Li; John F. Kincaid; Jeffrey M. Schkeryantz; John K. Lynch


Archive | 2004

Non-nucleotide compositions and method for treating pain

Robert Plourde; Sammy Ray Shaver; Melwyn Abreo; Lorenzo Josue Alfaro-Lopez; Yangbo Feng; Tatyana V. Khasanova; Mark W. Holladay; Christopher S. Crean


Archive | 2008

Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents

Serguei Sviridov; Vishnumurthy Kodumuru; Shifeng Liu; Melwyn Abreo; Michael D. Winther; Heinz W. Gschwend; Rajender Kamboj; Shaoyi Sun; Mark W. Holladay; Wenbao Li; Chi Tu


Archive | 2000

Tricyclic dihydropyrimidine potassium channel openers

Mark W. Holladay; William A. Carroll; Irene Drizin; Lin Yi; Henry Q. Zhang


Archive | 2008

3-PYRIDYL ENANTIOMER AND ITS USE AS ANALGESIC

Stephen P. Arneric; Hao Bai; Michael J. Dart; Paul Ehrlich; Mark W. Holladay; Nan-Horng Lin; John K. Lynch; Yat Sun Or; Keith B. Ryther; James P. Sullivan; James T. Wasicak; キース・ビー・ライサー; ジエイムズ・テイー・ワシカツク; ジエイムズ・ピー・サリバン; ジヨン・ケイ・リンチ; ステイーブン・ピー・アーネリツク; ナン−ホルン・リン; ハオ・バイ; ポール・ピー・エールリツヒ; マーク・ダブリユ・ホラデイ; マイケル・ジエイ・ダート; ヤツト・スン・オー


Archive | 2006

Use of an scd-1 inhibitor to reduce adverse weight gain arising from drug therapy

Melwyn Abreo; Mikhail A. Kondratenko; Daniel F. Harvey; Cindy J. Hudson; Wenbao Li; Chi Tu; Sengen Sun; Mark W. Holladay; Heinz W. Gschwend; Nagasree Chakka; Zaihui Zhang; Shaoyi Sun; Vishnumurthy Kodumuru; Serguei Sviridov; Sultan Chowdhury; Mikhail Chafeev; Robert Fraser; Jianmin Fu; Duanjie Hou; Rajender Kamboj; Shifeng Liu; Vandna Raina; Kashinath Sadalapure; Bagherzadeh Mehran Seid; Michael D. Winther


Archive | 2004

Derives de piperazine et utilisation comme agents therapeutiques

Serguei Sviridov; Vishnumurthy Kodumuru; Shifeng Liu; Melwyn Abreo; Michael D. Winther; Heinz W. Gschwend; Rajender Kamboj; Shaoyi Sun; Mark W. Holladay; Wenbao Li; Chi Tu

Collaboration


Dive into the Mark W. Holladay's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge